A scientific nutrition strategy improves time trial performance by ≈6% when compared with a self-chosen nutrition strategy in trained cyclists: a randomized cross-over study

2012 ◽  
Vol 37 (4) ◽  
pp. 637-645 ◽  
Author(s):  
Kuno Hottenrott ◽  
Erik Hass ◽  
Manon Kraus ◽  
Georg Neumann ◽  
Martin Steiner ◽  
...  
Keyword(s):  
Oxygen Uptake ◽  
Endurance Exercise ◽  
Maximal Oxygen Uptake ◽  
Sodium Intake ◽  
Time Trial ◽  
Endurance Performance ◽  
Bicycle Ergometer ◽  
Time Trial Performance ◽  
Trial Performance ◽  
Nutrition Strategy

We investigated whether an athlete’s self-chosen nutrition strategy (A), compared with a scientifically determined one (S), led to an improved endurance performance in a laboratory time trial after an endurance exercise. S consisted of about 1000 mL·h–1 fluid, in portions of 250 mL every 15 min, 0.5 g sodium·L–1, 60 g glucose·h–1, 30 g fructose·h–1, and 5 mg caffeine·kg body mass–1. Eighteen endurance-trained cyclists (16 male; 2 female) were tested using a randomized crossover-design at intervals of 2 weeks, following either A or S. After a warm-up, a maximal oxygen uptake test was performed. Following a 30-min break, a 2.5-h endurance exercise on a bicycle ergometer was carried out at 70% maximal oxygen uptake. After 5 min of rest, a time trial of 64.37 km (40 miles) was completed. The ingested nutrition was recorded every 15 min. In S, the athletes completed the time trial faster (128 vs. 136 min; p ≤ 0.001) and with a significantly higher power output (212 vs. 184 W; p ≤ 0.001). The intake of fluid, energy (carbohydrate-, mono-, and disaccharide), and sodium was significantly higher in S compared with A (p ≤ 0.001) during the endurance exercise. In the time trial, only sodium intake was significantly higher in S (p ≤ 0.001). We concluded that a time trial performance after a 2.5-h endurance exercise in a laboratory setting was significantly improved following a scientific nutrition strategy.

scholarly journals The Effects of Inhaled Terbutaline on 3-km Running Time-Trial Performance

2019 ◽  
Vol 14 (6) ◽  
pp. 822-828 ◽  
Author(s):  
John Molphy ◽  
John W. Dickinson ◽  
Neil J. Chester ◽  
Mike Loosemore ◽  
Gregory Whyte
Keyword(s):  
Repeated Measures ◽  
Time Trial ◽  
Endurance Performance ◽  
Forced Expiratory Volume ◽  
Concentration Data ◽  
Running Performance ◽  
Running Time ◽  
Time Trial Performance ◽  
Repeated Measures Design ◽  
Trial Performance

Terbutaline is a prohibited drug except for athletes with a therapeutic use exemption certificate; terbutaline’s effects on endurance performance are relatively unknown. Purpose: To investigate the effects of 2 therapeutic (2 and 4 mg) inhaled doses of terbutaline on 3-km running time-trial performance. Methods: A total of 8 men (age 24.3 [2.4] y; weight 77.6 [8] kg; and height 179.5 [4.3] cm) and 8 women (age 22.4 [3] y; weight 58.6 [6] kg; and height 163 [9.2] cm) free from respiratory disease and illness provided written informed consent. Participants completed 3-km running time trials on a nonmotorized treadmill on 3 separate occasions following placebo and 2- and 4-mg inhaled terbutaline in a single-blind, repeated-measures design. Urine samples (15 min postexercise) were analyzed for terbutaline concentration. Data were analyzed using 1-way repeated-measures analysis of variance, and significance was set at P < .05 for all analyses. Results: No differences were observed for completion times (1103 [201] s, 1106 [195] s, 1098 [165] s; P = .913) for the placebo or 2- and 4-mg inhaled trials, respectively. Lactate values were higher (P = .02) after 4 mg terbutaline (10.7 [2.3] mmol·L−1) vs placebo (8.9 [1.8] mmol·L−1). Values of forced expiratory volume in the first second of expiration (FEV1) were greater after inhalation of 2 mg (5.08 [0.2]; P = .01) and 4 mg terbutaline (5.07 [0.2]; P = .02) compared with placebo (4.83 [0.5] L) postinhalation. Urinary terbutaline concentrations were mean 306 (288) ng·mL−1 and 435 (410) ng·mL−1 (P = .2) and peak 956 ng·mL−1 and 1244 ng·mL−1 after 2 and 4 mg inhaled terbutaline, respectively. No differences were observed between the male and female participants. Conclusions: Therapeutic dosing of terbutaline does not lead to an improvement in 3-km running performance despite significantly increased FEV1. The findings suggest that athletes using inhaled terbutaline at high therapeutic doses to treat asthma will not gain an ergogenic advantage during 3-km running performance.

Metabolic and performance responses during endurance exercise after high-fat and high-carbohydrate meals

1998 ◽  
Vol 85 (2) ◽  
pp. 418-424 ◽  
Author(s):  
Helena A. Whitley ◽  
S. M. Humphreys ◽  
I. T. Campbell ◽  
M. A. Keegan ◽  
T. D. Jayanetti ◽  
...  
Keyword(s):  
Fatty Acids ◽  
Oxygen Uptake ◽  
Endurance Exercise ◽  
Maximal Oxygen Uptake ◽  
Time Trial ◽  
Substrate Oxidation ◽  
High Fat ◽  
High Carbohydrate ◽  
And Performance ◽  
Fat Meal

We studied the effects of preexercise meal composition on metabolic and performance-related variables during endurance exercise. Eight well-trained cyclists (maximal oxygen uptake 65.0 to 83.5 ml ⋅ kg−1 ⋅ min−1) were studied on three occasions after an overnight fast. They were given isoenergetic meals containing carbohydrate (CHO), protein (P), and fat (F) in the following amounts (g/70 kg body wt): high-carbohydrate meal, 215 CHO, 26 P, 3 F; high-fat meal, 50 CHO, 14 P, 80 F. On the third occasion subjects were studied after an overnight fast. Four hours after consumption of the meal, subjects started exercise for 90 min at 70% of their maximal oxygen uptake, followed by a 10-km time trial. The high-carbohydrate meal compared with the high-fat meal resulted in significant decreases ( P < 0.05) in blood glucose, plasma nonesterified fatty acids, plasma glycerol, plasma chylomicron-triacylglycerol, and plasma 3-hydroxybutyrate concentrations during exercise. This was accompanied by an increase in plasma insulin ( P < 0.01 vs. no meal), plasma epinephrine, and plasma growth hormone concentrations (each P < 0.05 vs. either of the other conditions) during exercise. Despite these large differences in substrate and hormone concentrations in plasma, substrate oxidation during the 90-min exercise period was similar in the three trials, and there were no differences in performance on the time trial. These results suggest that, although the availability of fatty acids and other substrates in plasma can be markedly altered by dietary means, the pattern of substrate oxidation during endurance exercise is remarkably resistant to alteration.

Improved Cycling Time-Trial Performance after Ingestion of a Caffeine Energy Drink

2009 ◽  
Vol 19 (1) ◽  
pp. 61-78 ◽  
Author(s):  
John L. Ivy ◽  
Lynne Kammer ◽  
Zhenping Ding ◽  
Bei Wang ◽  
Jeffrey R. Bernard ◽  
...  
Keyword(s):  
Perceived Exertion ◽  
Time Trial ◽  
Endurance Performance ◽  
Energy Drink ◽  
Rating Of Perceived Exertion ◽  
Double Blind ◽  
Time Trial Performance ◽  
Cycling Time Trial ◽  
Cycling Time ◽  
Trial Performance

Context:Not all athletic competitions lend themselves to supplementation during the actual event, underscoring the importance of preexercise supplementation to extend endurance and improve exercise performance. Energy drinks are composed of ingredients that have been found to increase endurance and improve physical performance.Purpose:The purpose of the study was to investigate the effects of a commercially available energy drink, ingested before exercise, on endurance performance.Methods:The study was a double-blind, randomized, crossover design. After a 12-hr fast, 6 male and 6 female trained cyclists (mean age 27.3 ± 1.7 yr, mass 68.9 ± 3.2 kg, and VO2 54.9 ± 2.3 ml · kg–1 · min–1) consumed 500 ml of either flavored placebo or Red Bull Energy Drink (ED; 2.0 g taurine, 1.2 g glucuronolactone, 160 mg caffeine, 54 g carbohydrate, 40 mg niacin, 10 mg pantothenic acid, 10 mg vitamin B6, and 10 μg vitamin B12) 40 min before a simulated cycling time trial. Performance was measured as time to complete a standardized amount of work equal to 1 hr of cycling at 70% Wmax.Results:Performance improved with ED compared with placebo (3,690 ± 64 s vs. 3,874 ± 93 s, p < .01), but there was no difference in rating of perceived exertion between treatments. β-Endorphin levels increased during exercise, with the increase for ED approaching significance over placebo (p = .10). Substrate utilization, as measured by open-circuit spirometry, did not differ between treatments.Conclusion:These results demonstrate that consuming a commercially available ED before exercise can improve endurance performance and that this improvement might be in part the result of increased effort without a concomitant increase in perceived exertion.

scholarly journals Efficacy of Ingesting an Oral Rehydration Solution after Exercise on Fluid Balance and Endurance Performance

Nutrients ◽  
2020 ◽  
Vol 12 (12) ◽  
pp. 3826
Author(s):  
Priscilla Weiping Fan ◽  
Stephen F. Burns ◽  
Jason Kai Wei Lee
Keyword(s):  
Relative Humidity ◽  
Fluid Balance ◽  
Completion Time ◽  
Oral Rehydration Solution ◽  
Time Trial ◽  
Endurance Performance ◽  
Oral Rehydration ◽  
Time Trial Performance ◽  
Rehydration Solution ◽  
Trial Performance

This study investigated the efficacy of ingesting an oral rehydration solution (DD) that has a high electrolyte concentration after exercise on fluid balance and cycling performance in comparison with a sports drink (SD) and water (WA). Nine healthy males aged 24 ± 2 years (mean ± SD), with peak oxygen uptake (VO2 peak) 55 ± 6 mL·kg−1·min−1 completed three experimental trials in a randomised manner ingesting WA, SD (carbohydrates: 62 g·L−1, sodium: 31 ± 3 mmol·L−1) or DD (carbohydrates: 33 g·L−1, sodium: 60 ± 3 mmol·L−1). On all trials, fluid was ingested during 75 min cycling at 65% VO2 peak (temperature: 30.4 ± 0.3 °C, relative humidity: 76 ± 1%, simulated wind speed: 8.0 ± 0.6 m·s−1) and during 2 h of recovery (temperature: 23.0 ± 1.0 °C, relative humidity: 67 ± 2%), with the total volume equivalent to 150% of sweat loss during the ride. A 45 min pre-load cycling time trial at a 65% VO2 peak followed by a 20 km time trial was conducted after a further 3 h of recovery. Fluid retention was higher with DD (30 ± 15%) than WA (−4 ± 19%; p < 0.001) and SD (10 ± 15%; p = 0.002). Mean ratings of palatability were similar among drinks (WA: 4.25 ± 2.60; SD: 5.61 ± 1.79; DD: 5.40 ± 1.58; p = 0.33). Although time trial performance was similar across all three trials (WA: 2365 ± 321 s; SD: 2252 ± 174 s; DD: 2268 ± 184 s; p = 0.65), the completion time was faster in eight participants with SD and seven participants with DD than with WA. Comparing SD with DD, completion time was reduced in five participants and increased in four participants. DD was more effective at restoring the fluid deficit during recovery from exercise than SD and WA without compromising the drink’s palatability with increased sodium concentration. Most individuals demonstrated better endurance exercise time trial performance with DD and SD than with WA.

No Improvement in Endurance Performance after a Single Dose of Beetroot Juice

2012 ◽  
Vol 22 (6) ◽  
pp. 470-478 ◽  
Author(s):  
Naomi M. Cermak ◽  
Peter Res ◽  
Rudi Stinkens ◽  
Jon O. Lundberg ◽  
Martin J. Gibala ◽  
...  
Keyword(s):  
Repeated Measures ◽  
Time Trial ◽  
Endurance Performance ◽  
Beetroot Juice ◽  
Double Blind ◽  
Single Bolus ◽  
Time Trial Performance ◽  
Subsequent Time ◽  
The Impact ◽  
Trial Performance

Introduction:Dietary nitrate supplementation has received much attention in the literature due to its proposed ergogenic properties. Recently, the ingestion of a single bolus of nitrate-rich beetroot juice (500 ml, ~6.2 mmol NO3−) was reported to improve subsequent time-trial performance. However, this large volume of ingested beetroot juice does not represent a realistic dietary strategy for athletes to follow in a practical, performancebased setting. Therefore, we investigated the impact of ingesting a single bolus of concentrated nitrate-rich beetroot juice (140 ml, ~8.7 mmol NO3−) on subsequent 1-hr time-trial performance in well-trained cyclists.Methods:Using a double-blind, repeated-measures crossover design (1-wk washout period), 20 trained male cyclists (26 ± 1 yr, VO2peak 60 ± 1 ml · kg−1 · min−1, Wmax 398 ± 7.7 W) ingested 140 ml of concentrated beetroot juice (8.7 mmol NO3−; BEET) or a placebo (nitrate-depleted beetroot juice; PLAC) with breakfast 2.5 hr before an ~1-hr cycling time trial (1,073 ± 21 kJ). Resting blood samples were collected every 30 min after BEET or PLAC ingestion and immediately after the time trial.Results:Plasma nitrite concentration was higher in BEET than PLAC before the onset of the time trial (532 ± 32 vs. 271 ± 13 nM, respectively; p < .001), but subsequent time-trial performance (65.5 ± 1.1 vs. 65 ± 1.1 s), power output (275 ± 7 vs. 278 ± 7 W), and heart rate (170 ± 2 vs. 170 ± 2 beats/min) did not differ between BEET and PLAC treatments (all p > .05).Conclusion:Ingestion of a single bolus of concentrated (140 ml) beetroot juice (8.7 mmol NO3−) does not improve subsequent 1-hr time-trial performance in well-trained cyclists.

Effect of a divided caffeine dose on endurance cycling performance, postexercise urinary caffeine concentration, and plasma paraxanthine

2003 ◽  
Vol 94 (4) ◽  
pp. 1557-1562 ◽  
Author(s):  
Kylie J. Conway ◽  
Rhonda Orr ◽  
Stephen R. Stannard
Keyword(s):  
Oxygen Uptake ◽  
Maximal Oxygen Uptake ◽  
Time Trial ◽  
Endurance Performance ◽  
Cycling Performance ◽  
Urinary Concentration ◽  
Caffeine Concentration ◽  
Double Blind ◽  
Caffeine Ingestion ◽  
Dose Dependent Fashion

This study compared the effects of a single and divided dose of caffeine on endurance performance and on postexercise urinary caffeine and plasma paraxanthine concentrations. Nine male cyclists and triathletes cycled for 90 min at 68% of maximal oxygen uptake, followed by a self-paced time trial (work equivalent to 80% of maximal oxygen uptake workload over 30 min) with three randomized, balanced, and double-blind interventions: 1) placebo 60 min before and 45 min into exercise (PP); 2) single caffeine dose (6 mg/kg) 60 min before exercise and placebo 45 min into exercise (CP); and 3) divided caffeine dose (3 mg/kg) 60 min before and 45 min into exercise (CC). Time trial performance was unchanged with caffeine ingestion ( P = 0.08), but it tended to be faster in the caffeine trials (CP: 24.2 min and CC: 23.4 min) compared with placebo (PP: 28.3 min). Postexercise urinary caffeine concentration was significantly lower in CC (3.8 μg/ml) compared with CP (6.8 μg/ml). Plasma paraxanthine increased in a dose-dependent fashion and did not peak during exercise. In conclusion, dividing a caffeine dose provides no ergogenic effect over a bolus dose but reduces postexercise urinary concentration.

Effect of inhaled terbutaline on substrate utilization and 300-kcal time trial performance

2014 ◽  
Vol 117 (10) ◽  
pp. 1180-1187 ◽  
Author(s):  
Anders Kalsen ◽  
Morten Hostrup ◽  
Sebastian Karlsson ◽  
Peter Hemmersbach ◽  
Jens Bangsbo ◽  
...  
Keyword(s):  
Drug Exposure ◽  
Time Trial ◽  
Endurance Performance ◽  
Substrate Utilization ◽  
Submaximal Exercise ◽  
Double Blind ◽  
Muscle Lactate ◽  
Lactate Accumulation ◽  
Time Trial Performance ◽  
Trial Performance

In a randomized, double-blind crossover design, we investigated the effect of the beta2-agonist terbutaline (TER) on endurance performance and substrate utilization in nine moderately trained men [maximum oxygen uptake (V̇o2 max) 58.9 ± 3.1 ml·min−1·kg−1]. Subjects performed 60 min of submaximal exercise (65–70% of V̇o2 max) immediately followed by a 300-kcal time trial with inhalation of either 15 mg of TER or placebo (PLA). Pulmonary gas exchange was measured during the submaximal exercise, and muscle biopsies were collected before and after the exercise bouts. Time trial performance was not different between TER and PLA (1,072 ± 145 vs. 1,054 ± 125 s). During the submaximal exercise, respiratory exchange ratio, glycogen breakdown (TER 266 ± 32, PLA 195 ± 28 mmol/kg dw), and muscle lactate accumulation (TER 20.3 ± 1.6, PLA 13.2 ± 1.2 mmol/kg dw) were higher ( P < 0.05) with TER than PLA. There was no difference between TER and PLA in net muscle glycogen utilization or lactate accumulation during the time trial. Intramyocellular triacylglycerol content did not change with treatment or exercise. Pyruvate dehydrogenase-E1α phosphorylation at Ser293 and Ser300 was lower ( P < 0.05) before submaximal exercise with TER than PLA, with no difference after the submaximal exercise and the time trial. Before submaximal exercise, acetyl-CoA carboxylase 2 (ACC2) phosphorylation at Ser221 was higher ( P < 0.05) with TER than PLA. There was no difference in phosphorylation of alpha 5′-AMP-activated protein kinase (αAMPK) at Thr172 between treatments. The present study suggests that beta2-agonists do not enhance 300-kcal time trial performance, but they increase carbohydrate metabolism in skeletal muscles during submaximal exercise independent of AMPK and ACC phosphorylation, and that this effect diminishes as drug exposure time, exercise duration, and intensity are increased.

Oxygen Uptake and Endurance Fitness in Children: A Developmental Perspective

1989 ◽  
Vol 1 (4) ◽  
pp. 313-328 ◽  
Author(s):  
Thomas W. Rowland
Keyword(s):  
Body Weight ◽  
Oxygen Uptake ◽  
Endurance Exercise ◽  
Maximal Oxygen Uptake ◽  
Oxygen Delivery ◽  
Endurance Performance ◽  
Submaximal Exercise ◽  
Endurance Capacity ◽  
Exercise Economy ◽  
Qualitative Changes

In adults, maximum oxygen uptake (VO2max) serves as a useful indicator of cardiopulmonary reserve as well as performance in endurance exercise events. Whether VO2max can be interpreted in the same manner in children is less certain, since maximal oxygen uptake per kg body weight remains essentially stable during the growing years while endurance performance improves dramatically. Gains in ability in endurance events may be achieved through improved submaximal exercise economy, qualitative changes in oxygen delivery not indicated by VO2max, or the development of nonaerobic factors (speed, strength). Maximal oxygen uptake in children may therefore be a less valid indicator of cardiopulmonary function, endurance capacity, and response to training than in adult subjects.

Improved endurance capacity following chocolate milk consumption compared with 2 commercially available sport drinks

2009 ◽  
Vol 34 (1) ◽  
pp. 78-82 ◽  
Author(s):  
Kevin Thomas ◽  
Penelope Morris ◽  
Emma Stevenson
Keyword(s):  
Oxygen Uptake ◽  
Endurance Exercise ◽  
Maximal Oxygen Uptake ◽  
Recovery Period ◽  
Endurance Performance ◽  
Fluid Replacement ◽  
Endurance Capacity ◽  
Milk Consumption ◽  
Chocolate Milk ◽  
Experimental Trials

This study examined the effects of 3 recovery drinks on endurance performance following glycogen-depleting exercise. Nine trained male cyclists performed 3 experimental trials, in a randomized counter-balanced order, consisting of a glycogen-depleting trial, a 4-h recovery period, and a cycle to exhaustion at 70% power at maximal oxygen uptake. At 0 and 2 h into the recovery period, participants consumed chocolate milk (CM), a carbohydrate replacement drink (CR), or a fluid replacement drink (FR). Participants cycled 51% and 43% longer after ingesting CM (32 ± 11 min) than after ingesting CR (21 ± 8 min) or FR (23 ± 8 min). CM is an effective recovery aid after prolonged endurance exercise for subsequent exercise at low-moderate intensities.

Sign in / Sign up

Export Citation Format

Share Document